MAIA Biotechnology, Inc. MAIA
1.01 USD +0.01 (+1.00%)
As ofNov 16, 2026, 2:29 PM EST
0.9599 Day range 1.02
0.87 52-week range 3.19
- YTD
- -33.99%
- 1 year
- -2.88%
- Market cap
- 62.37M
- EPS (ttm)
- -0.47
- Shares out
- 25.33M
- Forward P/E
- -1.25
- YTD return
- -33.99%
- 1-year return
- -2.88%
- 50-day average
- 2.41
- 200-day average
- 2.83
- Enterprise value
- 51.06M
- Volume
- 488.93K
- Avg volume
- 447.69K
- Open
- 1.00
- Previous close
- 1.00
- Day's range
- 0.9599 – 1.02
- 52-week range
- 0.87 – 3.19
- Beta
- 0.34
- Analysts
- Strong Buy
- Price target
- 12.63 (+1150.0%)
5D -0.06 (-5.61%)
Key statistics
- Price / book
- 70.36
- Free cash flow
- -8.81M
- Total cash
- 11.58M
- Return on equity
- -559.56%
- Short % of float
- 3.30%
Fundamental scorecard
7 of 25 checks passed on MAIA’s reported financials
7of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
MAIA Revenue — quarterly 0
MAIA Net income — quarterly -7.18M
MAIA EPS — quarterly -0.12
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 21, 2023 | Noble Capital Markets | init | — | Outperform |
About MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- maiabiotech.com
News
Your note
Sign in to keep a note on MAIA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHAOUKI STEVEN M | Director | Purchase | Mar 13, 2024 | 88,891 |
| GUERRERO RAMIRO | Director | Purchase | Dec 12, 2024 | 514,970 |
| LOUIE NGAR YEE | Director | Purchase | Apr 24, 2024 | 1,167,190 |
| LUPUT CRISTIAN | Director | Purchase | Oct 31, 2024 | 389,483 |
| MCGUIRE JOSEPH F | Chief Financial Officer | Purchase | Apr 26, 2023 | 9,400 |
| SMITH STAN V | Director | Purchase | Oct 31, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 2.24% | 566,374 | 1.12M | Sep 29, 2024 |
| Halter Ferguson Financial Inc. | 1.49% | 376,714 | 742.13K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.76% | 192,563 | 379.35K | Sep 29, 2024 |
| Blackrock Inc. | 0.31% | 79,727 | 157.06K | Sep 29, 2024 |
| Centric Wealth Management | 0.27% | 68,219 | 134.39K | Sep 29, 2024 |
| Bridgeway Capital Management, Inc. | 0.18% | 45,700 | 90.03K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.59% | 401,588 | 791.13K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.61% | 153,385 | 302.17K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.43% | 108,755 | 214.25K | Oct 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.18% | 45,700 | 90.03K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.14% | 36,051 | 71.02K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.12% | 29,164 | 57.45K | Oct 30, 2024 |
